These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 8961963)

  • 21. Function of topoisomerase II and the consequences of inhibition.
    Davies SM
    Med Pediatr Oncol Suppl; 1996; 1():12-9. PubMed ID: 8643041
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy-related acute myeloid leukemia: role of DNA repair].
    Guièze R; Ravinet A; Hermet E; Maliki Y; de Botton S; Bay JO
    Bull Cancer; 2011 Mar; 98(3):247-55. PubMed ID: 21427028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The secondary leukemias: challenges and research directions.
    Smith MA; McCaffrey RP; Karp JE
    J Natl Cancer Inst; 1996 Apr; 88(7):407-18. PubMed ID: 8618232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiopurines, DNA damage, DNA repair and therapy-related cancer.
    Karran P
    Br Med Bull; 2006; 79-80():153-70. PubMed ID: 17277075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].
    Dassonneville L; Bailly C
    Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA damage and repair in human cancer: molecular mechanisms and contribution to therapy-related leukemias.
    Casorelli I; Bossa C; Bignami M
    Int J Environ Res Public Health; 2012 Aug; 9(8):2636-57. PubMed ID: 23066388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Second cancers associated with the cancer treatment and their possible control].
    Abe T; Nomura K
    Nihon Rinsho; 2003 Jun; 61(6):1045-51. PubMed ID: 12806958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of testicular cancer and the development of secondary malignancies.
    Bokemeyer C; Schmoll HJ
    J Clin Oncol; 1995 Jan; 13(1):283-92. PubMed ID: 7799032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of DNA damage and repair upon the risk of treatment related leukemia.
    Guillem V; Tormo M
    Leuk Lymphoma; 2008 Feb; 49(2):204-17. PubMed ID: 18231906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular pathogenesis of treatment-induced (secondary) leukemias: foundations for treatment and prevention.
    Karp JE; Smith MA
    Semin Oncol; 1997 Feb; 24(1):103-13. PubMed ID: 9045296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second primary tumours (SPTs) after chemotherapy.
    Cartei G; Liguori S; Tabaro G; Cartei F
    Eur J Cancer Prev; 1996 Oct; 5(5):400-2. PubMed ID: 8972275
    [No Abstract]   [Full Text] [Related]  

  • 32. [Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
    Su Y; Zhou X; Zhang L; Zhang R
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):938-42. PubMed ID: 24495767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy of secondary leukemias.
    Visani G; Pagano L; Pulsoni A; Tosi P; Piccaluga PP; Pastano R; Grafone T; Malagola M; Isidori A; Tura S
    Leuk Lymphoma; 2000 May; 37(5-6):543-9. PubMed ID: 11042514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature.
    Setoodeh R; Zhang L
    Leuk Lymphoma; 2012 Apr; 53(4):736-8. PubMed ID: 21980957
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical cancer chronotherapy trials: a review.
    Bjarnason GA
    J Infus Chemother; 1995; 5(1):31-7. PubMed ID: 7634175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cellular and molecular mechanisms of carcinogenic side effects and resistance to BRAF inhibitors in metastatic melanoma with BRAFV600 mutation: state of the knowledge].
    Capovilla M
    Ann Pathol; 2013 Dec; 33(6):375-85. PubMed ID: 24331719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy related leukemias: susceptibility, prevention and treatment.
    Leone G; Voso MT; Sica S; Morosetti R; Pagano L
    Leuk Lymphoma; 2001 Apr; 41(3-4):255-76. PubMed ID: 11378539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy-related myeloid neoplasms.
    Czader M; Orazi A
    Am J Clin Pathol; 2009 Sep; 132(3):410-25. PubMed ID: 19687318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary myelodysplastic syndromes and acute leukemias.
    Zeidman A; Dayan DB; Mittelman M
    Haematologia (Budap); 1995; 27(1):23-8. PubMed ID: 12051292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
    Petru E; Schmähl D
    Neoplasma; 1991; 38(2):147-55. PubMed ID: 2041574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.